Cargando…
Circulating miR-146a predicts glucocorticoid response in thyroid eye disease
OBJECTIVE: Thyroid eye disease (TED) is an immune-mediated disorder of the eye. Intravenous glucocorticoid (GC) is the first-line treatment for patients with active moderate-to-severe TED. However, the response rate is between 50% and 80%. There are still no simple and reliable markers of responsive...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563606/ https://www.ncbi.nlm.nih.gov/pubmed/37606076 http://dx.doi.org/10.1530/ETJ-23-0083 |